A Pathologist’s Guide to Research and Clinical Trials

The Royal College of Pathologists (RCPath) hosted this new conference with the National Cancer Research Institute (NCRI) initiative, CM-Path (Cellular molecular pathology initiative). The event aimed to provide pathologists with all the information required to effectively participate in clinical trial research.

» Download the agenda

Speaker Presentations

» Role of NCRI and Clinical Studies Groups – Dr Ian Lewis (PDF)

» Role of Pathologists in Clinical Study Groups – Dr Abeer Shabaan (PDF)

» Overview of potential pathology contribution to Clinical Trials – from inception to completion Part 1 – Dr Emily Shaw (PDF)

» Overview of potential pathology contribution to Clinical Trials – from inception to completion Part 2 – Professor Gary Middleton (PDF)

» Using tissue in Clinical Trials – rules and regulations, storage and access – Dr Bridget Wilkins (PDF)

» Pathology-based testing of tissues in Clinical Trials – Performance, Standardisation and Quality Control – Professor Adrienne Flanagan (PDF)

» Issues in interpretation of pathology tests – Dr Max Robinson (PDF)

» Training – What should a Clinical Trial Pathologists know? – Professor Manuel Salto-Tellez (PDF)

» Funding opportunities for Clinical Trial Pathologists – Professor Ian Cree (PDF)

For further information about this event or similar upcoming events, please email the CM-Path Programme Manager: jessica.lee@ncri.org.uk